Biosimulation Market is Projected to Reach $2,881 billion by 2022
The
global biosimulation
market is projected to reach USD 2,881 billion by 2022 from USD 1,375
billion in 2017, at a CAGR of 15.9%. Factors such as increase in R&D
investments in the pharmaceutical and biotechnology industries, growing
adoption of biosimulation software by regulatory bodies, technologically
advanced QSP systems, need to curtail drug discovery and development costs,...